现代时代感染性心内膜炎双瓣膜手术结局正在改善
2001至2021年间,211例感染性心内膜炎患者在一家三级转诊中心接受主动脉瓣与二尖瓣联合手术。30天死亡率为14%(n=30),1年死亡率为30%(n=61)。透析史(aHR 1.9;95%CI 1.3-2.9;P=.002)和静脉药物滥用史(aHR 2.0;95%CI 1.1-3.5;P=.02)预测生存率降低,2010年后手术预测生存率改善(aHR 0.5;95%CI 0.3-0.8;P=.006)。
要点
- 感染性心内膜炎双瓣膜手术后30天死亡率为14%,1年死亡率为30%。
- 透析史和静脉药物滥用史与生存率降低独立相关。
- 2010年后接受手术与生存率改善独立相关。
核心结论
- 在这项评估现代时代感染性心内膜炎双瓣膜手术结局的大型系列中,尽管死亡风险仍然较高,但结局改善可能与在显著疾病进展前更早进行手术干预相关。
- 作者认为可考虑对复杂感染性心内膜炎进行多学科评估,以更好地理解最佳时机和修复策略。
研究设计与样本
- 2001年至2021年间,211例感染性心内膜炎患者在一家三级转诊中心接受主动脉瓣与二尖瓣联合手术。
- 收集胸外科医师学会登记数据,包括人口统计学、手术细节和结局。
- 分析30天和1年死亡的危险因素,使用Kaplan-Meier和Cox比例风险模型分析生存率。
主要发现
- 队列以男性为主(73%),中位年龄56岁(四分位距[IQR],44至63岁)。
- 45例(21%)有静脉药物滥用史,50例(24%)术前透析,50例(24%)为人工瓣膜心内膜炎。
- 30天和1年死亡率分别为14%(n=30)和30%(n=61)。
- 多变量Cox回归调整年龄、人工瓣膜心内膜炎、术后主动脉内球囊反搏(IABP)后,透析史(aHR 1.9;95%CI 1.3至2.9;P=.002)和静脉药物滥用史(aHR 2.0;95%CI 1.1-3.5;P=.02)预测生存率降低。
- 2010年后接受手术预测生存率改善(aHR 0.5;95%CI 0.3至0.8;P=.006);这些患者更可能接受紧急/急诊手术(83% vs 29%;P<.001),更少出现主动脉根部脓肿(40% vs 58%;P=.03)或需要commando手术(13% vs 33%;P=.002)。
临床怎么用
- 作者认为可考虑对复杂感染性心内膜炎进行多学科评估,以更好地理解最佳时机和修复策略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The incidence of infective endocarditis (IE) is rapidly increasing. Contemporary outcomes following high-risk double valve surgery (DVS) for IE are not well described. METHODS: Between 2001 and 2021, 211 patients with IE underwent combined aortic and mitral valve surgery at a tertiary care referral center. Data from the Society of Thoracic Surgeons registry, including demographics, operative details, and outcomes, were collected. Risk factors for 30-day and 1-year-mortality were analyzed. Survival was analyzed using Kaplan-Meier and Cox proportional hazards modeling. RESULTS: The study cohort had a male preponderance (73%), with a median age of 56 years (interquartile range [IQR], 44 to 63 years). Forty-five patients (21%) had a history of intravenous (IV) drug abuse, 50 (24%) were on preoperative dialysis, and 50 (24%) had prosthetic valve endocarditis. Thirty-day and 1-year mortality were 14% (n = 30) and 30% (n = 61), respectively. On multivariable Cox regression adjusting for age, prosthetic valve endocarditis, postoperative intra-aortic balloon pump (IABP), history of dialysis (adjusted hazard ratio [aHR], 1.9; 95% confidence interval [CI], 1.3 to 2.9; P = .002) and IV drug abuse (aHR, 2.0; 95% CI, 1.1-3.5; P = .02) were predictive of decreased survival. Undergoing surgery after 2010 was predictive of improved survival (aHR, 0.5; 95% CI, 0.3 to 0.8; P = .006). These patients were more likely to undergo urgent/emergent surgery (83% vs 29%; P < .001) and less likely to have an aortic root abscess (40% vs 58%; P = .03) or to require the commando procedure (13% vs 33%; P = .002). CONCLUSIONS: In this large series evaluating outcomes of DVS for IE in the modern era, although the mortality risk remained elevated, improving outcomes may be associated with earlier surgical intervention before significant disease progression. Multidisciplinary evaluation for complex IE may be considered to better understand the optimal timing and repair strategy.
引用
- Miller PC, Schulte LJ, Marghitu T, et al. Outcomes of double-valve surgery for infective endocarditis are improving in the modern era. J Thorac Cardiovasc Surg. 2023. PMID: 37802331. doi:10.1016/j.jtcvs.2023.09.072
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。